In CCA, SRC activation has been linked to enhanced metastatic potential, partly through its interaction with growth factor receptors and downstream MAPK and PI3K/AKT pathways, which are sensitive to oxidative stress. The gene discussed is SRC; the disease is cholangiocarcinoma.